| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
neurotensin | 0.517 | 0.769 | 3.9E-05 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2000 | 2013 | ||||||||
|
FYN proto-oncogene, Src family tyrosine kinase | 0.556 | 0.731 | 0.99 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2000 | 2009 | ||||||||
|
SPG21 abhydrolase domain containing, maspardin | 0.695 | 0.500 | 6.6E-04 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
N-acetyltransferase 1 | 0.536 | 0.846 | 1.9E-14 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 2001 | 2017 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 2001 | 2018 | ||||||||
|
protein phosphatase 1 regulatory inhibitor subunit 1B | 0.617 | 0.500 | 0.24 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.370 | None | 1.000 | 5 | 0 | 2002 | 2014 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.340 | None | 0.750 | 4 | 0 | 2002 | 2008 | ||||||||
|
nuclear receptor subfamily 4 group A member 2 | 0.529 | 0.846 | 1.00 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
dopamine receptor D1 | 0.529 | 0.808 | 0.96 |
|
disease | 0.330 | None | 0.800 | 5 | 0 | 2003 | 2015 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.380 | None | 0.800 | 5 | 0 | 2003 | 2017 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 1 | 0.561 | 0.692 | 0.98 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2003 | 2013 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha1 | 0.563 | 0.577 | 0.91 |
|
disease | 0.340 | None | 0.667 | 3 | 0 | 2003 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily B member 6 | 0.428 | 0.846 | 1.9E-10 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2006 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha5 | 0.621 | 0.385 | 0.91 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
protein tyrosine kinase 2 beta | 0.448 | 0.808 | 0.94 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
N-ribosyldihydronicotinamide:quinone reductase 2 | 0.628 | 0.500 | 8.8E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
EPH receptor A8 | 0.686 | 0.346 | 1.8E-10 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | 0.656 | 0.462 | 1.5E-11 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 2004 | 2014 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2004 | 2018 | ||||||||
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha2 | 0.641 | 0.346 | 1.00 |
|
disease | 0.700 | None | 0.800 | 5 | 0 | 2004 | 2017 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.580 | None | 1.000 | 5 | 0 | 2004 | 2014 |